Inflammatory biomarkers of ischemic stroke

Area of Science:

• Neurology
• Immunology
• Biochemistry

Background:

• Ischemic stroke is a leading cause of death and disability globally.
• Current treatments primarily focus on early reperfusion, with limited pharmacological neuroprotective options.
• Inflammation is a key factor in stroke pathophysiology, making inflammatory mediators potential therapeutic targets.

Purpose of the Study:

• To review the role of inflammatory mediators in ischemic stroke.
• To explore cytokines, soluble adhesion molecules, and adipokines as prognostic markers.
• To assess the therapeutic potential of these mediators in stroke.

Main Methods:

• Systematic review of existing evidence.
• Analysis of the role of cytokines in stroke.
• Evaluation of soluble adhesion molecules' impact on stroke.
• Investigation of adipokines' involvement in stroke pathophysiology and prognosis.

Main Results:

• Cytokines, adhesion molecules, and adipokines significantly influence ischemic stroke development and outcomes.
• These mediators show potential as biomarkers for stroke prognosis.
• Evidence suggests these inflammatory factors could be targets for novel neuroprotective therapies.

Conclusions:

• Inflammatory mediators are integral to ischemic stroke.
• Targeting cytokines, adhesion molecules, and adipokines may offer new therapeutic avenues.
• Further research into these mediators could improve stroke treatment and patient outcomes.